Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06405152 · ClinicalTrials.gov registry record
Assessment of Macrophage Activation syndromE in STill's Disease
A clinical trial, sponsored by Swedish Orphan Biovitrum.
- Completed
- Registry status
- 75
- Enrollment target
NCT06405152 is a clinical trial that has completed, run by Swedish Orphan Biovitrum. The registered enrollment target is 75 participants.
The verdict
NCT06405152 has completed, sponsored by Swedish Orphan Biovitrum.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics
Interventions
- OTHER Chart review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-09-27 |
| Est. Completion | 2024-09-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06405152
The ClinicalTrials.gov registry entry for NCT06405152 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Orphan Biovitrum, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chart review is the first listed.
NCT06405152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06405152 about?
NCT06405152 is a clinical study titled "Assessment of Macrophage Activation syndromE in STill's Disease". Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics
What is the current status of trial NCT06405152?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2023-09-27. Estimated completion is 2024-09-26.
What interventions are being tested in trial NCT06405152?
The interventions under investigation include: Chart review (OTHER).
Who is sponsoring clinical trial NCT06405152?
This trial is sponsored by Swedish Orphan Biovitrum, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.